WHO warns of growing resistance to GSK’s HIV drug
Reuters The World Health Organization said on Tuesday resistance to GSK’s HIV drug dolutegravir has exceeded levels observed during its trials, citing observational and survey data received from a few countries. Resistance ranged from 3.9 per cent to 8.6 per cent and reached 19.6 per cent among people who have received and transitioned to a […]